State

Nebraska product recalls

73,741 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.

What the numbers show

Total: 4,580
Critical: 713
Severe: 1,345
Most recent: 2026-10-28

Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.

Which agencies issued them

These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,741 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

39701–39725 of 78321

SevereFDA (Drugs)·D-1137-2018·2018-09-05
Torrent Pharma Recalls Amlodipine and Valsartan Tablets Due to Carcinogen Impurity
Torrent Pharma Inc. is recalling Amlodipine and Valsartan Tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-204-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1131-2018·2018-09-05
AvKARE Recalls Valsartan Tablets Due to Carcinogen Impurity
AvKARE is recalling specific lots of Valsartan 80 mg tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets, USP 80 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-784-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1134-2018·2018-09-05
Torrent Pharma Recalls Valsartan Tablets Due to Carcinogen Impurity
Torrent Pharma Inc. is recalling specific batches of Valsartan Tablets USP, 80mg, because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets USP, 80mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-068-90
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1145-2018·2018-09-05
Torrent Pharma Recalls Amlodipine, Valsartan, and Hydrochlorothiazide Tablets Due to Impurity
Torrent Pharma Inc. is recalling Amlodipine, Valsartan, and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active ingredient.
Product
Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 5 mg/160 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-329-30
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·18V588000·2018-09-05
Navistar Recalls International Trucks Due to Fuel Line Burst Risk
Navistar is recalling specific International trucks because a restricted fuel pump screen may cause the fuel line to burst, leading to fuel leaks or engine stalling.
Product
INTERNATIONAL — INTERNATIONAL PROSTAR, LONESTAR, PAYSTAR, HX
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1167-2018·2018-09-05
Auro Pharmacies Recalls Methyl-Cobalamin Injectable Due to Sterility Concerns
Auro Pharmacies is recalling 74 vials of Methyl-Cobalamin injectable because the manufacturer could not assure the sterility of the product.
Product
Methyl-Cobalamin injectable, 2 mg/mL, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1154-2018·2018-09-05
Pharmcore Recalls Methylcobalamin Vials Due to Sterility Concerns
Pharmcore Inc. is recalling 1,115 vials of Methylcobalamin 10 mg due to a lack of assurance of sterility. The product was distributed nationwide.
Product
Methylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1139-2018·2018-09-05
Torrent Pharma Recalls Amlodipine and Valsartan Tablets Due to Impurity
Torrent Pharma Inc. is recalling Amlodipine and Valsartan Tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Amlodipine and Valsartan Tablets, USP, 10 mg/160mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-206-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1155-2018·2018-09-05
Pharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
Pharmcore Inc. is recalling 599 vials of Ipamorelin 9 mg because the company cannot assure the sterility of the product.
Product
Ipamorelin 9 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1136-2018·2018-09-05
Torrent Pharma Recalls Valsartan Tablets Due to Carcinogen Impurity
Torrent Pharma Inc. is recalling specific batches of Valsartan Tablets USP, 320mg, because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets USP, 320mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-070-90
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1164-2018·2018-09-05
Auro Pharmacies Recalls Testosterone Cypionate/Enanthate Injectable Due to Sterility Concerns
Auro Pharmacies is recalling 32 vials of Testosterone Cypionate/Enanthate injectable because inadequate processes and equipment failed to assure the sterility of the product.
Product
Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 mL and 8 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1132-2018·2018-09-05
AvKARE Recalls Valsartan Tablets Due to Carcinogen Impurity in API
AvKARE, Inc. is recalling specific lots of Valsartan Tablets 160 mg because a carcinogen impurity was detected in the active pharmaceutical ingredient used to manufacture the drug.
Product
Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1153-2018·2018-09-05
Pharmcore Recalls Ipamorelin Vials Due to Sterility Assurance Concerns
Pharmcore Inc. is recalling Ipamorelin 3 mg vials because the company cannot ensure the product is sterile.
Product
Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1142-2018·2018-09-05
Torrent Pharma Recalls Amlodipine, Valsartan, and Hydrochlorothiazide Tablets Due to Impurity
Torrent Pharma Inc. is recalling specific lots of Amlodipine, Valsartan, and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 5 mg/160 mg/12.5 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-326-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1135-2018·2018-09-05
Torrent Pharma Recalls Valsartan Tablets Due to Carcinogen Impurity
Torrent Pharma Inc. is recalling specific batches of Valsartan Tablets USP, 160mg, because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1160-2018·2018-09-05
Auro Pharmacies Recalls Methyl-Cobalamin Injectable Due to Sterility Concerns
Auro Pharmacies, Inc. is recalling 114 vials of Methyl-Cobalamin injectable because inadequate processes and equipment failed to assure product sterility.
Product
Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·18V579000·2018-09-05
Toyota Recalls 2016-2018 Prius Vehicles for Electrical Fire Risk
Toyota is recalling 2016-2018 Prius vehicles because a worn engine wire harness could cause an electrical short and increase the risk of a fire.
Product
TOYOTA — TOYOTA PRIUS
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1166-2018·2018-09-05
Auro Pharmacies Recalls Folic Acid Injectable Due to Sterility Concerns
Auro Pharmacies, Inc. is recalling 40 vials of Folic Acid injectable due to inadequate processes and equipment to assure sterility.
Product
Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1150-2018·2018-09-05
Pharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
Pharmcore Inc. is recalling 3,070 vials of Human Chorionic Gonadotropin 2500 IU due to a lack of assurance of sterility. The recall is nationwide.
Product
Human Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1152-2018·2018-09-05
Pharmcore Recalls Human Chorionic Gonadotropin Vials Due to Sterility Concerns
Pharmcore Inc. is recalling 3,351 vials of Human Chorionic Gonadotropin 6000 IU due to a lack of assurance of sterility.
Product
Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1144-2018·2018-09-05
Torrent Pharma Recalls Amlodipine, Valsartan, and Hydrochlorothiazide Tablets
Torrent Pharma Inc. is recalling specific batches of Amlodipine, Valsartan, and Hydrochlorothiazide tablets due to the detection of a carcinogen impurity in the active pharmaceutical ingredient.
Product
Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/160 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-328-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-2941-2018·2018-09-05
MedComp Recalls DUO FLOW Custom Trays Due to Suture Wing Cracking
Medical Components, Inc dba MedComp is recalling DUO FLOW Custom Trays because suture wings may crack or break, posing risks of catheter dislocation, bleeding, and air emboli.
Product
DUO FLOW CUSTOM TRAYS; TRAY #414 TRAY #415 TRAY #67
Category
Medical Device
Distribution
Distributed nationwide
SevereNHTSA·18E088000·2018-09-05
AXN Heavy Duty Recalls Trailer Axles Due to Wheel Separation Risk
AXN Heavy Duty LLC is recalling certain trailer axles because the wheel end nut locking device may not be properly installed, allowing the wheel end to separate from the axle.
Product
SUSPENSION:REAR:AXLE:NON-POWERED AXLE ASSEMBLY recall
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1159-2018·2018-09-05
Auro Pharmacies Recalls Glutathione Injectable Due to Sterility Concerns
Auro Pharmacies is recalling 183 vials of Glutathione injectable because inadequate processes and equipment were used to assure the sterility of the product.
Product
Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1141-2018·2018-09-05
Torrent Pharma Recalls Amlodipine, Valsartan, and Hydrochlorothiazide Tablets Due to Impurity
Torrent Pharma Inc. is recalling specific batches of Amlodipine, Valsartan, and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active pharmaceutical ingredient.
Product
Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/320 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-325-30
Category
Drug
Distribution
Distributed nationwide